MULTI-LUMEN SYRINGES FOR INTRAOCULAR INJECTIONS

Abstract

There is provided herein a multi-lumen syringe for intraocular injection, including a first lumen, a second lumen, one or more needles fluidly connected to the lumens, and a needle sheath disposed about the one or more needles; wherein the needle sheath includes a plurality of n proximity/contact/pressure actuators on a distal rim of the needle sheath; wherein the syringe is switchable between at least two configurations: a first configuration in which at least one of the actuators is not actuated and each tip of the one or more needles is proximally positioned, and secured, relative to the distal rim; and a second configuration in which the n actuators are actuated, and the one or more needles are allowed to distally extend beyond the distal rim.

Claims

1.-49. (canceled)

50. A multi-lumen syringe for intraocular injection, comprising a first lumen, a second lumen, one or more needles fluidly connected to the lumens, and a needle sheath disposed about the one or more needles; wherein the needle sheath comprises a plurality of n proximity/contact/pressure actuators on a distal rim of the needle sheath; wherein the syringe is switchable between at least two configurations: a first configuration in which at least one of the actuators is not actuated and each tip of the one or more needles is proximally positioned, and secured, relative to the distal rim; and a second configuration in which the n actuators are actuated, and the one or more needles distally extendible beyond the distal rim.

51. The multi-lumen syringe of claim 50, wherein a plane defined by the distal rim of the needle sheath is perpendicular, or substantially perpendicular, to the one or more needles, thereby ensuring that when all, or substantially all, of the distal rim contacts a surface of an eye such as to actuate the n actuators, the one or more needles are insertable perpendicularly to the surface of the eye.

52. The multi-lumen syringe of claim 51, wherein the syringe is configured to automatically switch back from the second configuration to the first configuration, thereby ensuring that, after insertion of the one or more needles, if the syringe is tilted such that the distal rim no longer fully or substantially fully contacts the surface of the eye, injection or withdrawal of fluids is no longer possible.

53. The multi-lumen syringe of claim 50, wherein the actuators are push buttons, and in the second configuration the push buttons are pushed in beyond a threshold extent.

54. The multi-lumen syringe of claim 50, wherein in at least one pair of actuators, from the n actuators, the actuators are oppositely or substantially oppositely positioned on the distal rim.

55. The multi-lumen syringe of claim 51, wherein the actuators are contact/pressure actuators and wherein positionings of the actuators on the distal rim are such that, when the distal rim is placed on an eye of a subject, the syringe cannot be switched from the first configuration to the second configuration unless all, or substantially all, of the distal rim contacts the eye.

56. The multi-lumen syringe of claim 50, wherein the one or more needles are retractable and wherein the needle sheath is fixed.

57. The multi-lumen syringe of claim 50, wherein the needle sheath is retractable and/or compressible and wherein the one or more needles are fixed.

58. The multi-lumen syringe of claim 50, wherein the one or more needles comprise at least two needles: a first needle and a second needle, wherein the first needle is fluidly connected to the first lumen and the second needle is fluidly connected to the second needle.

59. The multi-lumen syringe of claim 50, further comprising a first plunger, configured for reciprocal motion within the first lumen, and a second plunger, configured for reciprocal motion within the second lumen.

60. The multi-lumen syringe of claim 59, wherein the first plunger and the second plunger are functionally associated such that pushing or pulling the first plunger induces a counter motion of the second plunger, and/or pushing or pulling the second plunger induces a counter motion of the first plunger.

61. The multi-lumen syringe of claim 59, further comprising a locking mechanism configured to allow the first plunger to be pushed only upon indication that the second plunger was shifted to a pulled configuration, thereby ensuring eye fluid withdrawal prior to injection and/or wherein the locking mechanism is configured to allow the first plunger to be pulled only upon indication that the second plunger was shifted to a pushed configuration, thereby ensuring injection prior to eye fluid withdrawal.

62. The multi-lumen syringe of claim 59, wherein the first plunger is configured such as to prevent pushing and/or pulling thereof beyond a threshold pushing velocity of the first plunger and/or a threshold pulling velocity of the first plunger.

63. The multi-lumen syringe of claim 50, further comprising at least one substance facilitating rapid analysis of eye-fluid through an interaction of the substance with the eye-fluid.

64. The multi-lumen syringe of claim 63, wherein the at least one substance is located in the lumen(s)/sub-lumen(s) of the syringe.

65. The multi-lumen syringe of claim 63, wherein the rapid analysis comprises Enzyme-Linked Immunosorbent Assay (ELISA).

66. The multi-lumen syringe of claim 63, wherein the rapid analysis comprises a color-yielding chemical reaction between a chemical indicator and an intraocular substance.

67. A method for injecting and/or withdrawing fluid to/from the eye of a subject, the method comprises: utilizing a multi lumen syringe comprising a first lumen, a second lumen, one or more needles fluidly connected to the lumens and a first plunger, configured for reciprocal motion within the first lumen, and a second plunger, configured for reciprocal motion within the second lumen; contacting the eye with a distal tip of the syringe; inserting at least one of the needles into the eye; pulling the first plunger of the syringe to withdraw fluid from the eye; and pushing the second plunger of the syringe to insert fluid to the eye.

68. The method of claim 67, wherein pulling the first plunger and pushing the second plunger is performed simultaneously.

69. The method of claim 67, wherein further comprising utilizing at least one substance present in the syringe, performing a rapid analysis of eye-fluid through an interaction of the substance with the eye-fluid.

Description

BRIEF DESCRIPTION OF THE FIGURES

[0127] Some embodiments of the disclosure are described herein with reference to the accompanying figures. The description, together with the figures, makes apparent to a person having ordinary skill in the art how some embodiments may be practiced. The figures are for the purpose of illustrative description and no attempt is made to show structural details of an embodiment in more detail than is necessary for a fundamental understanding of the disclosure. For the sake of clarity, some objects depicted in the figures are not to scale.

[0128] In the figures:

[0129] FIG. 1a is a schematic exploded view of a multi-lumen syringe, according to some exemplary embodiments;

[0130] FIG. 1b schematically depicts a distal section of the multi-lumen syringe of FIG. 1a, according to some embodiments;

[0131] FIG. 2 schematically depicts the multi-lumen syringe of FIG. 1a with needles thereof inserted into an eye of a subject, according to some exemplary embodiments;

[0132] FIG. 3 is a cross-sectional view of lumens of a multi-lumen syringe, according to some embodiments;

[0133] FIG. 4 is a schematic partial view of a fenestrated needle, according to some embodiments;

[0134] FIG. 5 is a schematic partial view of a needle including one or more cutting elements, according to some embodiments;

[0135] FIG. 6 is a schematically partial view of a double-needle syringe, wherein each of the needles is fenestrated and/or includes cutting elements, according to some embodiments; and

[0136] FIG. 7 schematically depicts a station for injecting fluid into, and/or drawing fluid from, an eye of a subject, according to some embodiments.

DETAILED DESCRIPTION

[0137] The principles, uses, and implementations of the teachings herein may be better understood with reference to the accompanying description and figures. Upon perusal of the description and figures present herein, one skilled in the art will be able to implement the teachings herein without undue effort or experimentation. In the figures, same reference numerals refer to same parts throughout.

[0138] In the description and claims of the application, the words “include” and “have”, and forms thereof, are not limited to members in a list with which the words may be associated.

[0139] As used herein, the term “about” may be used to specify a value of a quantity or parameter (e.g. the length of an element) to within a continuous range of values in the neighborhood of (and including) a given (stated) value. According to some embodiments, “about” may specify the value of a parameter to be between 80% and 120% of the given value. For example, the statement “the length of the element is equal to about 1 m” is equivalent to the statement “the length of the element is between 0.8 m and 1.2 m”. According to some embodiments, “about” may specify the value of a parameter to be between 90% and 110% of the given value. According to some embodiments, “about” may specify the value of a parameter to be between 95% and 105% of the given value.

[0140] As used herein, according to some embodiments, the terms “substantially” and “about” may be interchangeable.

[0141] As used herein, according to some embodiments, the term “fluid” may refer to liquid, gel or gas. For example, “fluid” may refer to a gas, such as CO.sub.2, gas carrying a drug, drug, a solution, such as a saline solution, a drug containing solution, a suspension, such as a drug particles/droplet-containing suspension, etc. According to some embodiments, the term “fluid” may also refer to the eye fluid. According to some embodiments, the term “drug” may refer to any pharmaceutically active ingredient, such as but not limited to, a compound, a combination of compounds or a composition, with or without carriers and/or excipients. The drug may be in the form of liquid, gel, dissolved/suspended particles or gas.

[0142] For ease of description, in some of the figures a three-dimensional cartesian coordinate system (with orthogonal axes x, y, and z) is introduced. It is noted that the orientation of the coordinate system relative to a depicted object may vary from one figure to another. Further, the symbol ⊙ is used in the figures to represent an axis pointing “out of the page”.

[0143] As used herein, according to some embodiments, the term “longitudinal” with reference to a direction/axis, refers to a direction/axis along/parallel to/opposite to the z-axis. According to some embodiments, the term “distal” with reference to a direction, refers to a direction along the negative z-axis. According to some embodiments, the term “proximal” with reference to a direction, refers to a direction along the positive z-axis. According to some embodiments, the term “distal” with reference to a location (e.g. of an element/component) may refer to a location near or in a body of a subject, while the term “proximal” refer to a location further away from the body of the subject (relative to the distal location).

[0144] According to an aspect of some embodiments, there is provided a multi-lumen syringe. FIG. 1a is a schematic exploded view of a multi-lumen syringe 100. According to some embodiments, syringe 100 includes a first lumen 102, a second lumen 104, a first needle 112, a second needle 114, a first plunger 122, a second plunger 124, and a needle sheath 140. First needle 112 is fluidly connected to first lumen 102. Second needle 114 is fluidly connected to second lumen 104. First plunger 122 is configured for controllable reciprocal motion within first lumen 102. Second plunger 124 is configured for controllable reciprocal motion within second lumen 104.

[0145] First needle 112 includes a first needle tip 126 (at the distal end thereof). Second needle 114 includes a second needle tip 128 (at the distal end thereof). First plunger 122 includes a first plunger seal 132 (e.g. at the distal end thereof). Second plunger 124 includes a second plunger seal 134 (at the distal end thereof).

[0146] According to some embodiments, and as depicted in the figures, second lumen 104 is longitudinally disposed inside first lumen 102 along the length thereof. According to some such embodiments, first lumen 102 and second lumen 104 are concentrically disposed. According to some embodiments, and as depicted in the figures, second needle 114 is longitudinally disposed inside first needle 112 along the length thereof. According to some such embodiments, first needle 112 and second needle 114 are concentrically disposed.

[0147] An injection volume of 0.05 mL is most commonly used. The maximum safe volume to inject without pre-injection drawing of the substance is believed to be 0.1 mL to 0.2 mL. Therefore, according to some embodiments, drawing and/or injecting of the substance may be conducted in a range of 0-0.4 mL, so that the net amount is an addition or reduction of about 0.2 mL of substance from the eye.

[0148] According to some embodiments, the needle size may vary according to the substance injected, with 27-gauge needles often used for crystalline substances such as triamcinolone acetonide and 30-gauge needles commonly used for the anti-VEGF agents ranibizumab, bevacizumab, and aflibercept. Studies suggest that smaller, sharper needles require less force for penetration and result in less drug reflux. Some physicians have begun using 31-gauge needles (the size commonly used by diabetic patients to test blood sugar and inject insulin), as smaller needle size may decrease patient discomfort.

[0149] The above needle gauges are relevant for external first needle 112. As such, second needle 114 is characterized by a smaller gauge.

[0150] Needle length may be between about 0.5 and 0.62 inches (12.7 to 15.75 mm). Longer needles may increase risk of retinal injury if the patient accidentally moves forward during the procedure.

[0151] According to some embodiments, not depicted in the figures, second needle 114 is adjacent to first needle 112.

[0152] Needle sheath 140 is longitudinally disposed about first needle 112 (and second needle 114) and terminates in a distal rim 142. According to some embodiments, and as depicted in the figures, needle sheath 140 is cylindrical. According to some embodiments, distal rim 142 is oval or elliptical. According to some embodiments, and as depicted in the figures, distal rim 142 is circular. According to some such embodiments, a radius of distal rim 142 (and needle sheath 140) is between about 3 mm and about 4 mm, thereby allowing an operator of syringe 100 to reliably inject at a (recommended) distance of about 3 mm to about 4 mm from a limbus of an eye of a subject.

[0153] According to some embodiments, needle sheath 140 is connected to outer walls (not numbered) of first lumen 102. According to some embodiments, needle sheath 140 is of a greater diameter than first lumen 102, and needle sheath 140, or at least a proximal portion thereof, is configured to slide on first lumen 102. Distal rim 142 includes a plurality of n actuators 148 (shown in FIG. 1b). According to some embodiments, the distance between adjacent actuators (from actuators 148) is the same, or substantially the same, for all pairs of adjacent actuators. According to some embodiments, actuators 148 are actuated when a pressure above a pressure threshold is applied thereon. According to some such embodiments, actuators 148 include pressure sensors. According to some embodiments, actuators are actuated by contact. According to some such embodiments, actuators 148 include contact sensors. According to some embodiments, actuators 148 include proximity sensors. According to some embodiments, and as depicted in FIG. 1b, actuators 148 are push buttons and are actuated when pushed in beyond a threshold extent/level. According to some such embodiments, one or more actuators 148 or one or more dedicated sensors (located on distal rim 142) may enable to measure the intraocular pressure (for example, but not limited to, measuring proximately or relative proximately to the various ocular surfaces, i.e. the cornea or sclera) in various methods known in the art used for reading the intraocular pressure. In some embodiments, actuators 148 or one or more dedicated sensors (located on distal rim 142) may operate in a closed loop system controlling (for example, limiting) the movement of plunger 124 and/or 122 and/or total volume of matter injected and/or drawn from the eye based on the measured intraocular pressure. In some embodiments of the system, feedback to the operator may be given by presenting the eye pressure on a display unit or by sound (not shown).

[0154] Syringe 100 is controllably switchable between two configurations: a first configuration and a second configuration. In the first configuration at least m (wherein 1≤m≤n−1) of actuators 148 are not actuated (so that n−m or fewer of actuators 148 are actuated) and needle tips 126 and 128 are proximally positioned, and secured, relative to distal rim 142. That is, first needle tip 126 and second needle tip 128 are not exposed. In the second configuration, at least n−m+1 of actuators 148 are actuated (so that m−1 or fewer of actuators 148 are not actuated) and needle tips 126 and 128 may be exposed (i.e. needle tips 126 and 128 may distally extend beyond distal rim 142). Each pair of values of n and m corresponds to a separate embodiment.

[0155] According to some embodiments, in the second configuration, needles 112 and 114 and needle sheath 140 are capable of a relative motion with respect to one another (such as to allow exposing needle tips 126 and 128).

[0156] More specifically, syringe 100 is configured to switch from the first configuration to the second configuration when the number of actuators (from actuators 148), which are actuated, reaches n−m+1, and to switch from the second configuration to the first configuration when the number of actuators which are actuated drops below n−m+1.

[0157] According to some embodiments, in the first configuration at least one of actuators 148 is not actuated (i.e. m=1) and in the second configuration all of actuators 148 are actuated.

[0158] According to some embodiments, needle sheath 140 is fixed, and needles 112 and 114 are configured for longitudinal (i.e. distal and proximal) motion in the second configuration. According to some embodiments, needles 112 and 114 are fixed, and needle sheath 140 is configured for longitudinal motion in the second configuration.

[0159] According to some embodiments, needles 112 and 114 and needle sheath 140 are configured for longitudinal counter motions in the second configuration (that is, when needles 112 and 114 motion is distal, needle sheath 140 motion is proximal, and vice-versa). According to some embodiments, a proximal end 152 of needle sheath 140 is fixed and in the second configuration distal rim 142 is retractable. That is, needle sheath 140 is configured to allow compression thereof in the second configuration.

[0160] According to additional or alternative embodiments, syringe 100 may be controllably switchable between two configurations: a first configuration and a second configuration. In the first configuration at least m (wherein 1≤m≤n−1) of actuators 148 are not actuated and plungers 124 and/or 122 are locked. In the second configuration, at least n−m+1 of actuators 148 are actuated and plungers 124 and/or 122 are free to be pulled/pushed. This may ensure that no injection or withdrawal of liquid to/from the eye will be allowed unless the syringe is essentially perpendicular to the eye surface and in appropriate contact therewith.

[0161] Making reference also to FIG. 1b, FIG. 1b schematically depicts a distal section 158 of syringe 100, according to some embodiments thereof wherein actuators 148 are push-buttons.

[0162] Making reference also to FIG. 2, FIG. 2 schematically depicts syringe 100 and an eye 200, according to some embodiments. Syringe 100 is shown with needles 112 and 114 inserted into eye 200. More specifically, distal rim 142 is shown contacting a surface 202 of eye 200 such that needles 112 and 114 are inserted into eye 200 at right angles (perpendicularly) to surface 202, which increases the safety and reliability of intraocular injections, thereby minimizing potential damage to the lens, retina and other ocular structures.

[0163] In use, syringe 100 may be switched from the first configuration to the second configuration by bringing distal rim 142 against a surface (e.g. surface 202 of eye 200) such as to actuate at least n−m+1 of actuators 148. Syringe 100 may be configured such that when distal rim 142 is brought against a flat or rounded surface (in particular, a surface of eye) with at least n−m+1 of actuators 148 being actuated, needles 112 and 114 are positioned at right angles, or substantially at right angles, to the surface.

[0164] According to some embodiments, distal rim 142 defines a plane perpendicular to needles 112 and 114, so that by bringing all of distal rim 142 into contact with a flat or rounded surface, a perpendicular positioning of needles 112 and 114 relative to the surface is ensured. According to some such embodiments, the actuation of all of actuators 148 ensures that all, or substantially all, of distal rim 142 is in contact with the surface, and that needles 112 and 114 are perpendicular, or substantially perpendicular, to the surface. According to some embodiments, at least two of actuators 148, e.g. actuators 148a and 148b in FIG. 1b, are oppositely positioned on distal rim 142 (e.g. when distal rim 142 is circular, a diameter of distal rim 142 extends between the two actuators), thereby ensuring that when the two actuators are actuated by bringing distal rim 142 into contact with the surface of an eye, needles 112 and 114 are perpendicular to the surface.

[0165] As used herein, the term “rim” (e.g. distal rim 142) may refer to both thin and wide rims. For example, according to some embodiments, a surface area of distal rim 142 may measure between about 10% to about 90% of the total area of the plane defined by distal rim 142.

[0166] According to some embodiments, distal rim 142 is configured such as to allow stable mounting thereof on surface 202. For example, the dimensions of distal rim 142 may be selected to this end and/or distal rim 142 may be made of a material, or may be coated by a material, such as to facilitate stable contact between needle sheath 140 and eye 200 when distal rim 142 is brought there against. According to some embodiments, needle sheath 140 (or at least distal rim 142) may be broader (e.g. of greater diameter) than first lumen 102, or wider at least along one axis (e.g. when distal rim 142 is oval or cylindrical) such as to facilitate greater stability of contact between distal rim 142 and surface 202.

[0167] According to some embodiments, first plunger 122 and second plunger 124 operation is independent of one another. In particular, first plunger 122 may be pushed or pulled independently of second plunger 124 position and independently of whether second plunger is pushed or pulled, and vice-versa.

[0168] According to some embodiments, pushing and/or pulling of first plunger 122 may induce a counter-motion of second plunger 124, and/or vice-versa. For example, when second plunger 124 is pushed (e.g. injecting medicament into an eye of a subject), first plunger 122 is automatically pulled back (e.g. withdrawing fluid from the eye).

[0169] According to some embodiments, syringe 100 may have a plurality of counter-motion modes and may be controllably switched there between. As a non-limiting example, in a first counter-motion mode, an increase or decrease in the first volume is accompanied by an opposite-sign and equal magnitude change in the second volume (as described above), while in the second counter-motion mode, an increase or decrease in the first volume is accompanied by an opposite-sign and half-magnitude change in the second volume. That is, in the second counter-motion mode, when first needle 112 is used to inject a first amount of medicament, an amount of fluid equal to half of the first amount is withdrawn using second needle 114. The second counter-motion mode may be used for injecting into an eye with low intraocular pressure.

[0170] According to some embodiments, in cases where injection and withdrawal are performed essentially simultaneously, the length of first needle 112 may be different from the length of second needle 114 (not shown) such that each needle will reach a different location within the eye.

[0171] According to some embodiments, syringe 100 may operate in a free-motion mode, wherein motions of first plunger 122 and second plunger 124 are independent of one another.

[0172] According to some embodiments, syringe 100 may operate in a restricted-motion mode. According to some embodiments, syringe 100 includes a locking mechanism facilitating such operation. According to some embodiments, the locking mechanism is configured to allow first plunger 122 to be pushed (to inject fluid) only upon indication that second plunger 124 was shifted to a pulled configuration (to ensure that fluid was drawn from the eye prior to injection) and/or vice-versa (switching between the roles of the first and second plungers).

[0173] Additionally or alternatively, the locking mechanism may be configured to allow first plunger 122 to be pulled (to withdraw eye fluid) only upon indication that second plunger 124 was shifted to a pushed configuration (to ensure that fluid was injected into the eye prior to withdrawal) and/or vice-versa (switching between the roles of the first and second plungers).

[0174] According to some embodiments, syringe 100 is configured such that in the second configuration needles 112 and 114 (distally) can only project to a pre-determined extent relative to distal rim 142. According to some embodiments, the pre-determined extent is about 1 cm. The pre-determined extent is selected such as to guarantee, on the one hand, (i) safety of use of syringe 100 as a too deep insertion of a needle into the eye may damage/injure internal structures of the eye such as the retina, and, on the other hand, (ii) sufficiently deep insertion of needles 112 and 114, thereby ensuring penetration of all of the layers constituting the outer surfaces of the eye.

[0175] According to some embodiments, syringe 100 is configured to allow insertion of needles 112 and 114 into an eye of a subject at a pre-determined speed and/or pressure or at pre-determined range of speeds and/or pressures. This may help to reduce the discomfort experienced by the subject, particularly when a needle(s) is introduced into the eye too quickly or too slowly and/or with too much or too little force applied.

[0176] According to some embodiments, syringe 100 includes at least one additional lumen (not shown) longitudinally disposed about first lumen 102. According to some such embodiments, syringe 100 further includes at least one additional needle (not shown) longitudinally disposed about first needle 112. Additionally or alternatively, according to some embodiments, syringe 100 includes at least one additional lumen (not shown) longitudinally disposed inside second lumen 104. According to some such embodiments, syringe 100 further includes at least one additional needle (not shown) longitudinally disposed inside second needle 114.

[0177] FIG. 3 is a schematic cross-sectional view of a multi-lumen syringe 300, according to some embodiments. Syringe 300 is similar to syringe 100 but differs therefrom in that at least one of a first lumen 302 and a second lumen 304 thereof includes a plurality of sub-lumens extending longitudinally there along. More specifically, FIG. 3 is a schematic cross-sectional view of first lumen 302 and second lumen 304. According to some embodiments, and as depicted in FIG. 3, first lumen 302 is partitioned into a plurality of first lumen sub-lumens 352 extending in parallel to one another, and second lumen 304 is partitioned into a plurality of second lumen sub-lumens 354 extending in parallel to one another. According to some embodiments, each of first lumen sub-lumens 352 is fluidly connected to a first needle (not shown; similar to first needle 112) and each of second lumen sub-lumens 354 is fluidly connected to a second needle (not shown; similar to second needle 114).

[0178] As a non-limiting and illustrative example, in FIG. 3, first lumen 302 includes four sub-lumens (a sub-lumen 352a, a sub-lumen 352b, a sub-lumen 352c, and a sub-lumen 352d) and second lumen 304 includes four sub-lumens (a sub-lumen 354a, a sub-lumen 354b, a sub-lumen 354c, and a sub-lumen 354d).

[0179] According to some embodiments, syringe 300 includes a first plurality of plungers and a second plurality of plungers (not shown). Each plunger in the first plurality may be associated with a respective sub-lumen from first lumen sub-lumens 352. Each plunger in the second plurality may be associated with a respective sub-lumen from second lumen sub-lumens 354.

[0180] More generally, according to some embodiments, some of first lumen sub-lumens 352 and/or second lumen sub-lumens 354 may be associated with a common plunger, while other of first-lumen sub-lumens 352 and/or second lumen sub-lumens 354 may not be associated with a common plunger, being instead associated with a unique respective plunger.

[0181] According to some embodiments, syringe 300 includes one or more additional needles (not shown), such that some of first lumen sub-lumens 352 and/or some of second lumen sub-lumens 354 are fluidly associated with the one or more additional needles.

[0182] FIG. 4 is a schematic partial view of a fenestrated needle 400, according to some embodiments. Fenestrated needle 400 includes one or more side ports 406 along a shaft 408 of fenestrated needle 400. Side ports 406 may be, for example, circular, elliptical (as depicted in FIG. 4), or even rectangular. According to some embodiments, side ports 406 may differ from one another in shape and/or in size (e.g. in the length of the principle axis when side ports 406 are elliptical). Side ports 406 may also differ from one another in the positionings thereof along shaft 408. In particular, different side ports (from side ports 406) may differ from one another in respective distances thereof from a (distal) tip 410 of shaft 408, and/or may be located opposite, or substantially opposite, to one another (i.e. on opposite walls of shaft 408).

[0183] According to some embodiments, side ports 406 may be located on a distal portion of shaft 408, such as to help ensure that side ports 406 are positioned within the vitreous when fenestrated needle 400 is properly inserted into an eye of a subject, and thereby increase the safety of the procedure.

[0184] According to some embodiments, side ports 406 may further function as cutting elements, since motion of fenestrated needle 400 within the eye may result in the cutting of substances in the eye that come into contact with side ports 406. The motion may include longitudinal motion (e.g. reciprocating motion), transverse motion (e.g. back-and-forth motion on the yz-plane wherein the needle remains parallel to the z-axis throughout), rotations (about the z-axis and/or about the negative z-axis), vibrations, and/or a combination thereof. According to some embodiments, one or more of the listed motions may be oscillatory. According to some embodiments, the motions may be generated by a mechanical (pressure based), electrical, electromagnetic, electro-mechanic, or a piezo-electric motor (not shown), which may be housed, for example, in a lumen to which fenestrated needle 400 is fluidly-connected. According to some such embodiments, rims 418 of side ports 406 may be sharp (e.g. similarly to an edge of a razor blade) in order to increase the cutting efficacy of side ports 406.

[0185] Since (vitreous) fluid may be disposed in liquefied vitreous lacunae, the inclusion of side ports 406 (in addition to the port defined by tip 410) increases the likelihood of drawing fluid from the vitreous. More specifically, since the vitreous fluid does not form a single body of fluid within the vitreous, the addition of a plurality of side ports, which are distributed along the length of the needle shaft, increases the likelihood of the needle (when inserted into vitreous) establishing fluid-communication with more than a single body of fluid. Further, as mentioned above, side ports 406 may further act as a cutting elements, thereby potentially freeing fluid from lacunae positioned around fenestrated needle 400, which may then be withdrawn via side ports 406.

[0186] According to some embodiments, a fenestrated needle having no hole at the tip thereof (not shown) may also be applied. Such fenestrated needle includes only side ports similar to side ports 406 of fenestrated needle 400. Since such needle has no hole at the tip thereof, the tip may have a smaller diameter and can, thus, advantageously be very sharp.

[0187] Making reference again to syringe 100, according to some embodiments, not depicted in the figures, first needle 112 is fenestrated in an essentially similar manner to fenestrated needle 400 or to the fenestrated needle described hereinabove. Additionally or alternatively, second needle 114 may be fenestrated.

[0188] Making reference again to syringe 300, according to some embodiments, not depicted in the figures, a first needle of syringe 300 (i.e. the outer needle of syringe 300 which may be fluidly-connected to first lumen sub-lumens 352) is fenestrated, in an essentially similar manner to fenestrated needle 400 or to the fenestrated needle described hereinabove. Additionally or alternatively, a second needle of syringe 300 (i.e. the inner needle of syringe 300 which may be fluidly-connected to second lumen sub-lumens 354) may be fenestrated.

[0189] According to some embodiments, there is provided a multi-lumen syringe. The syringe may be similar to embodiments of syringe 100 or syringe 300 including a fenestrated needle such as fenestrated needle 400 (or the fenestrated needle described hereinabove) but differs therefrom in not including at least one of a needle sheath (e.g. such as needle sheath 140) and actuators such as actuators 148 or similar thereto.

[0190] FIG. 5 is a schematic partial view of a needle 500 including cutting elements, according to some embodiments. Needle 500 includes one or more external cutting elements 502 and/or one or more internal cutting elements 504. Motion of needle 500 within the eye may result in the cutting of substances therein which come into contact with cutting elements 502. The motion may include longitudinal motion (e.g. reciprocating motion), transverse motion, rotations, vibrations, and/or a combination thereof. According to some embodiments, one or more of the listed motions may be oscillatory. According to some embodiments, the motions may be generated by a mechanical (pressure based), electrical, electromagnetic, electro-mechanic, or a piezo-electric motor (not shown), which may be housed, for example, within needle 500 or within a lumen to which needle 500 is fluidly-connected.

[0191] Making reference again to syringe 100, according to some embodiments, not depicted in the figures, second needle 114 includes one or more external cutting elements, such as external cutting elements 502, and/or one or more internal cutting elements, such as internal cutting elements 504. Additionally or alternatively, according to some embodiments, first needle 112 includes one or more internal cutting elements. Optionally, first needle 112 may include one or more external cutting elements.

[0192] Making reference again to syringe 300, according to some embodiments, not depicted in the figures, the inner needle of syringe 300 includes one or more external cutting elements, such as external cutting elements 502, and/or one or more internal cutting elements, such as internal cutting elements 504. Additionally or alternatively, according to some embodiments, the outer needle of syringe 300 includes one or more internal cutting elements. Optionally, the outer needle of syringe 300 may include one or more external cutting elements.

[0193] According to some embodiments, there is provided a multi-lumen syringe. The syringe may be similar to embodiments of syringe 100 or syringe 300 including a needle with cutting elements needle such as needle 500 but differs therefrom in not including at least one of a needle sheath (e.g. such as needle sheath 140) and actuators such as actuators 148 or similar thereto.

[0194] FIG. 6 is a schematic partial view of a double-needle assembly 600, according to some embodiments. Double-needle assembly 600 includes a first needle 612 and a second needle 614. According to some embodiments, and as depicted in FIG. 6, second needle 614 is disposed within and along first needle 612. According to some embodiments, first needle 612 is fenestrated in an essentially similar manner to fenestrated needle 400. Additionally and/or alternatively, according to some embodiments, second needle 614 includes one or more external cutting elements, such as at least one external cutting element 656, and/or one or more internal cutting elements, such as at least one internal cutting elements 658. Additionally or alternatively, according to some embodiments, second needle 614 is fenestrated. Optionally, first needle 612 may include one or more internal and/or external cutting elements.

[0195] As a non-limiting example, and as depicted in FIG. 6, first needle 612 may include one or more ports 606 (such as one or more of ports 406), and second needle 614 may include at least one external cutting element 656 (such as one or more of external cutting elements 502) and at least one internal cutting element 658 (such as one or more of internal cutting elements 504). In some embodiments, one or more of at least one external cutting element 656 may be located at or proximal to one or more ports 606 enabling cutting of elements from the vitreous to enter through ports 606 or through the needle tip of the second lumen. In addition, in some embodiments, the internal cutting elements may be positioned on the first and/or second lumen and may cut elements from the vitreous entering though the needle tip.

[0196] According to some embodiments, double-needle assembly 600 may be configured to allow executing relative motion between first needle 612 and second needle 614, for example: (i) longitudinal reciprocating relative motion (wherein first needle 612 moves in a reciprocating manner while second needle 614 is stationary, second needle 614 moves in a reciprocating manner while first needle 612 is stationary, or wherein first needle 612 and second needle 614 move at different speeds, e.g. in opposite directions), (ii) transverse relative motion, (iii) relative rotational motion (wherein first needle 612 and second needle 614 rotate about the z-axis at different angular velocities, e.g. in opposite senses).

[0197] Making reference again to syringe 100, according to some embodiments, not depicted in the figures, wherein first needle 112 and/or second needle 114 are fenestrated (as described above) and/or include cutting elements (as described above), first needle 112 and second needle 114 are arranged in a double-needle configuration essentially similarly to first needle 612 and second needle 614 of double-needle assembly 600. In particular, first needle 112 and/or second needle 114 may be configured to realize relative motion there between as described above with respect to first needle 612 and second needle 614. According to some such embodiments, syringe 100 may be configured such that pushing and/or pulling one or both of first plunger 122 and second plunger 124 actuates motion of the cutting elements (e.g. actuates vibration thereof). Additionally and/or alternatively embodiments, syringe 100 may be configured such that pushing and/or pulling one or both of first plunger 122 second plunger 124, generates relative motion between first needle 112 and second needle 114 (e.g. relative longitudinal motion there between), thereby inducing motion (or additional motion) of the cutting elements.

[0198] Making reference again to syringe 300, according to some embodiments, not depicted in the figures, wherein the outer needle thereof (i.e. of syringe 300) and/or the inner needle thereof are fenestrated (as described above) and/or include cutting elements (as described above), the outer needle and the inner needle are arranged in a double-needle configuration essentially similarly to first needle 612 and second needle 614 of double-needle assembly 600. In particular, the outer needle and/or the inner needle (of syringe 300) may be configured to realize relative motion there between as described above with respect to first needle 612 and second needle 614. According to some such embodiments, syringe 300 may be configured such that pushing and/or pulling of one or more of the plungers of syringe 300 actuates motion of the cutting elements. Additionally and/or alternatively embodiments, syringe 300 may be configured such that pushing and/or pulling one or more of the plungers of syringe 300, generates relative motion between outer needle and the inner needle, thereby inducing motion (or additional motion) of the cutting elements.

[0199] According to some embodiments, there is provided a multi-lumen syringe. The syringe may be similar to embodiments of syringe 100 or syringe 300 including a double-needle assembly such as double-needle assembly 600 but differs therefrom in not including at least one of a needle sheath (e.g. such as needle sheath 140) and actuators such as actuators 148 or similar thereto.

[0200] According to some embodiments, there is provided a multi-lumen syringe. The syringe may be similar to syringe 100 or to syringe 300 but differs therefrom in including only a single needle similar to either first needle 112, fenestrated needle 400, or needle 500 or another needle configuration described herein above. Both a first lumen and a second lumen of the syringe (which are similar to first lumen 102 and second lumen 104, respectively, or to first lumen 302 and second lumen 304, respectively) are fluidly associated with the needle.

[0201] FIG. 7 schematically depicts a station 700 for injecting into, and/or drawing fluids from, an eye of a subject, according to some embodiments. Station 700 is configured to be used with a syringe 750, which is functionally associated with station 700. More specifically, according to some embodiments, station 700 may be configured to control operation of at least of some functions of syringe 750, such as, for example, a rate of injection(s). According to some embodiments, syringe 750 may be a multi-lumen syringe, such as multi-lumen syringe 100, multi-lumen syringe 300, the other multi-lumen syringes described herein above, and multi-lumen syringes similar thereto. According to some embodiments, syringe 750 may be a multi-lumen syringe similar to multi-lumen syringes 100 and 300 but differing therefrom in not including at least one of a needle sheath (e.g. such as needle sheath 140) and actuators such as actuators 148 or similar thereto. According to some alternative embodiments, syringe 750 may include only a single lumen, as elaborated on below.

[0202] According to some embodiments, station 700 includes a housing 701, which includes a monitor 703. Station 700 may further include a user operated controller 705. According to some embodiments, controller 705 is included in housing 701, for example, and as depicted in FIG. 7, in the form of a control panel 707 (e.g. a touch panel). A control circuitry (not shown) may be distributed between controller 705 and other parts of housing 701. The control circuitry (e.g. electronic circuitry, one or more computer processors and memory components) is configured to allow a user to operate/control functions of syringe 750 using controller 705. The control circuitry is further configured to control operation of monitor 703, and so on.

[0203] According to some embodiments, controller 705 may be detachably mounted on housing 701 (e.g. on a docking station which may be included as part of housing 701) and may be used both when docked and as a handheld device. According to some embodiments, controller 705 may include control panel 707, as well as one or more additional control accessories (not shown; which may control different functions from control panel 707), such as a foot pedal which may be configured to e.g. allow a user to control rate(s) of injection.

[0204] According to some embodiments, station 700 may further include a support structure 711 on which housing 701 may be mounted. According to some embodiments, support structure 711 includes a height-adjustable mount 723, whereon housing 701 may be mounted, and a base 727, which supports mount 723. According to some embodiments, station 700 is mobile. According to some such embodiments, base 727 is mounted on a mechanism which facilitates moving of station 700, such as wheels 729. According to some alternative embodiments, station 700 may be stationary.

[0205] As depicted in FIG. 7, housing 701 is configured to be fluidly coupled to syringe 750 via one or more tubes 731 (pipes) and/or one or more wires 733 (e.g. electrical wires and/or optical fibers). According to some embodiments, tubes 731 and wires 733 are detachably connectable to housing 701. According to some such embodiments, tubes 731, and optionally wires 733, are disposable, and may be replaced after each use. According to some embodiments, syringe 750 is disposable and may be replaced after each use. According to some embodiments, components of syringe 750, for example, a plunger(s), a lumen(s), and a needle(s) are disposable and may be replaced after each use, thereby minimizing the contamination of instruments/components due to a patient (subject). According to some such embodiments, syringe 750 may arrive “out of the box” connected to tubes 731, and optionally to wires 733. According to some embodiments, not depicted in FIG. 7 tubes 731 and wires 733 are disposed within a single cable. According to some embodiments, wires 733, and optionally tubes 731, and form part of station 700, and are detachably connectable to syringe 750.

[0206] It will be understood that syringe 750 may be a multi-lumen syringe and, in particular, an embodiment of multi-lumen syringe 100, multi-lumen syringe 300, each of the other multi-lumen syringes described hereinabove, or similar thereto. Each possibility corresponds to different embodiments. Different embodiments of tubes 731 may vary from one another in accordance with the multi-lumen syringe to which they are configured to be connected. For example, the number of tubes (in tubes 731) may vary in accordance with the number of lumens or sub-lumens in the multi-lumen syringe. In particular, according to some embodiments, the number of tubes may equal the number of lumens or the numbers of sub-lumens in the multi-lumen syringe to which they are intended to be respectively connected. Similarly, different embodiments of wires 733 may vary from one another in accordance with the multi-lumen syringe to which they are configured to be connected (e.g. in accordance with the number of plungers in the multi-lumen syringe).

[0207] According to some embodiments, operational parameters of syringe 750 may be controlled via controller 705, controller accessories (such as a foot pedal), and/or buttons and/or the like on tubes 731, wires 733, and/or syringe 750. As a non-limiting example, the operational parameters may include a volume of injected/withdrawn fluid, a force applied to insert a needle, a speed of insertion of needle, a rate of injection/fluid withdrawal, which lumens are operational and which are not (e.g. are blocked) during a use of the syringe 750 (i.e. controller 705 can be used “enable” and “disable” lumens), which lumen is to be used for injection and which lumen is to be used for withdrawal, and so on.

[0208] According to some embodiments, wherein syringe 750 includes a needle assembly, such as double-needle assembly 600, or similar thereto, relative motion of the needles (including the type of motion, e.g. longitudinal or rotational, the speed of motion) may be initiated/selected/controlled via controller 705, controller accessories, and/or buttons and/or the like on tubes 731, wires 733, and/or syringe 750. According to some embodiments, wherein a needle of syringe 750 includes cutting elements, such as cutting elements 502 and/or 504, motion of the cutting elements may be initiated/selected/controlled via controller 705, controller accessories, and/or buttons and/or the like on tubes 731, wires 733, and/or syringe 750.

[0209] According to some embodiments, tubes 731 and/or wires 733 may be functionally associated with one or more plungers of the syringe, one or more lumens and/or sub-lumens of the syringe, one or more components within the lumens and/or sub-lumens (such as motors to generate motion of the needles, motors to generate motion of the plungers, to apply positive or negative pressure to pneumatically mobilize the plungers, and/or to the substance in the lumens and/or to the needle(s)), one or more needles of the syringe, and/or one or more components within and/or on the needles (such as cutting elements), thereby functionally associating station 700 (i.e. the control circuitry in station 700) therewith.

[0210] According to some embodiments, station 700 may be configured to control the pressures in the lumens of syringe 750 (and in the sub-lumens in embodiments wherein the lumens of syringe 750 include sub-lumens). In particular, station 700 may be configured to generate positive and negative pressures within the lumens, to control the rates of change in the pressures, and thereby control the rates of fluid injections into the eye and fluid withdrawals therefrom. According to some embodiments, station 700 is configured to control the motion of the plungers and thereby control the pressures and rates of change thereof in the lumens of the syringe. According to some embodiments, station 700 may include a pump, which is mechanically coupled to the lumens in the syringe via tubes 731. According to some embodiments, the motion of plungers is controlled by the pump.

[0211] According to some embodiments, syringe 750 is a single-lumen syringe. According to some such embodiments, tubes 731 include two tubes which may effectively assume the role of the lumens in syringe 100, with a first of the two tubes being fluidly connected to first lumen 102 and the second of the two tubes being fluidly connected to second lumen 104. Similarly, according to some embodiments wherein syringe 750 is a single-lumen syringe, tubes 731 include, or consist of, a single double-lumened tube which may effectively assume the role of the lumens in syringe 100.

[0212] According to some embodiments in which syringe 750 is a single-lumen syringe, tubes 731 include a plurality of tubes which may effectively assume the role of the sub-lumens in syringe 300. According to some such embodiments, some of the tubes may be multi-lumened. Similarly, according to some embodiments wherein syringe 750 is a single-lumen syringe, tubes 731 include, or consist of, a single multi-lumened tube which may effectively assume the role of the lumens in syringe 100.

[0213] According to some embodiments, the control circuitry may include processing circuitry configured to analyze sensor readings from sensors positioned in syringe 750 (e.g. in one of the lumens used for drawing eye-fluid), in one or more tubes 731, and/even in housing 701. For example, according to some embodiments, wires 733 may include one or more optical fibers connected to a CCD sensor or a CMOS sensor in housing 701. In such embodiments, the processing circuitry may be configured to analyze image data from within the eye or of fluids within the lumens/sub-lumens. Alternatively, the optical sensors (e.g. the CMOS sensor) may be included in the syringe. The processing circuitry may include at least one computer processor and a memory configured to store analysis results. According to some embodiments, the computer processor may be configured to provide a diagnosis based on the analysis results. According to some embodiments, the processing and/or memory storage, and/or analysis of results may be performed in a remote central location (e.g. server). Such remote central location (e.g. server) is configured to receives and analyze results obtained from one or more stations such as station 700. According to some embodiments, monitor 703 may be configured to display the analysis results (and the diagnosis in embodiments wherein a diagnosis is provided).

[0214] According to some embodiments, housing 701 may include a compartment configured to house one or more removable fluid containers (not shown). The containers may be fluidly connectable to tubes 731, which in turn may be fluidly connected to the lumens in syringe 750, thereby allowing to fluidly couple the lumens to the containers. In such embodiments, a fluid intended for injection may be stored in a respective container in station 700. Other containers may be intended for fluid withdrawal and may initially be empty (i.e. prior to a use of station 700) or may include a substance configured to interact with withdrawn fluid. According to some embodiments, containers including withdrawn fluid may be removed for lab analysis. According to some embodiments, station 700 may include equipment configured to analyze the withdrawn fluid or at least to provide an initial analysis thereof. According to additional/alternative embodiments, station 700 may include equipment configured to transmit and/or receive readings to/from a remote central location (e.g. server or servers).

[0215] According to some embodiments, housing 701, one or more of tubes 731, and/or syringe 750 may include at least one substance facilitating rapid analysis of eye-fluid through an interaction of the substance with the eye-fluid.

[0216] According to some embodiments, monitor 703 may be configured to display analyzed data from rapid analysis of eye-fluid in a qualitative, semi-quantitative, and/or quantitative format.

[0217] According to some embodiments, syringe 750 may be an embodiment of a syringe known in the art. According to some embodiments, syringe 750 may be made of parts described in FIGS. 1-6, including but limited to the plungers, lumens, sub-lumens, and needles in a multi-lumen needle formation, a single needle formation, or any combination of needles 112, 114, 400, and 500, and double-needle assembly 600.

[0218] It is appreciated that certain features of the disclosure, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the disclosure, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable sub-combination or as suitable in any other described embodiment of the disclosure. No feature described in the context of an embodiment is to be considered an essential feature of that embodiment, unless explicitly specified as such.

[0219] Although steps of methods according to some embodiments may be described in a specific sequence, methods of the disclosure may include some or all of the described steps carried out in a different order. A method of the disclosure may include a few of the steps described or all of the steps described. No particular step in a disclosed method is to be considered an essential step of that method, unless explicitly specified as such.

[0220] Although the disclosure is described in conjunction with specific embodiments thereof, it is evident that numerous alternatives, modifications and variations that are apparent to those skilled in the art may exist. Accordingly, the disclosure embraces all such alternatives, modifications and variations that fall within the scope of the appended claims. It is to be understood that the disclosure is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth herein. Other embodiments may be practiced, and an embodiment may be carried out in various ways.

[0221] The phraseology and terminology employed herein are for descriptive purpose and should not be regarded as limiting. Citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the disclosure. Section headings are used herein to ease understanding of the specification and should not be construed as necessarily limiting.